SCHEMBL9101593

SCHEMBL9101593

Oc1ccc(CCCc2ccc(Cl)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.59
ESR2 Q92731 1/20 0.59
IGF1R P08069 2/20 0.59
ALOX15 P16050 2/20 0.59
CALM1 P0DP23 1/20 0.55
SLC28A3 Q9HAS3 1/20 0.55
ADRA2A P08913 3/20 0.54
SLC6A2 P23975 3/20 0.54
ADORA3 P0DMS8 2/20 0.54
TACR2 P21452 2/20 0.54
SLC6A4 P31645 2/20 0.54
SLC6A3 Q01959 2/20 0.54
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 2/20 0.54
LMNA P02545 1/20 0.54
SHBG P04278 1/20 0.54
TP53 P04637 1/20 0.54
CYP3A4 P08684 1/20 0.54
HSPD1 P10809 1/20 0.54
ADRB3 P13945 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9657346 0.93 ESR1 (0.63) ESR1ESR2IGF1RALOX15ADRA2A
SCHEMBL5647781 0.90 ESR1 (0.74) ESR1ESR2IGF1RALOX15ADRA2A
SCHEMBL18050371 0.87 TAAR1 (0.62) IGF1RALOX15LMNAHTR3ATAAR1
SCHEMBL245139 0.87 ESR1 (0.77) ESR1ESR2IGF1RALOX15CALM1
SCHEMBL1171041 0.87 ESR1 (0.77) ESR1ESR2IGF1RALOX15CALM1
SCHEMBL10365734 0.82 IGF1R (0.64) IGF1RALOX15LMNAHTR3ATAAR1
SCHEMBL449737 0.82 ESR1 (0.77) ESR1ESR2IGF1RALOX15CALM1
SCHEMBL9460441 0.81 MEN1 (0.49) ESR1ESR2IGF1RALOX15ADRA2A
SCHEMBL3155617 0.80 ESR1 (0.65) ESR1ESR2IGF1RALOX15CALM1
SCHEMBL2289447 0.80 ESR1 (0.74) ESR1ESR2NPC1RAB9ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0712388-A1 USE OF PHENOLS AND PHENOL DERIVATES AS MEDICAMENTS WITH FIBRINOGEN-REDUCING EFFECT Roche Diagnostics GmbH (DE) 1996-05-22 EP disclosed
WO-1995005358-A1 USE OF PHENOLS AND PHENOL DERIVATES AS MEDICAMENTS WITH FIBRINOGEN-REDUCING EFFECT BOEHRINGER MANNHEIM GMBH (DE) 1995-02-23 WO disclosed